About Assertio
Assertio is a company based in Lake Forest (United States) founded in 1995.. The company has 58 employees as of December 31, 2024. Assertio has completed 2 acquisitions, including OTREXUP and Spectrum Pharmaceuticals. Assertio offers products and services including Pharmaceutical Products and Business Development Services. Assertio operates in a competitive market with competitors including Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others.
- Headquarter Lake Forest, United States
- Employees 58 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Assertio Therapeutics, Inc
-
Annual Revenue
$124.96 M-17.83as on Dec 31, 2024
-
Net Profit
$-21.58 M93.5as on Dec 31, 2024
-
EBITDA
$8.96 M-83.15as on Dec 31, 2024
-
Latest Funding Round
$575 M (USD), Debt – Conventional
Mar 12, 2015
-
Investors
Oxford Finance
& 10 more
-
Employee Count
58
as on Dec 31, 2024
-
Investments & Acquisitions
OTREXUP
& 1 more
-
Acquired by
(Apr 08, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Assertio
Assertio is a publicly listed company on the NASDAQ with ticker symbol ASRT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Assertio
Assertio offers a comprehensive portfolio of products and services, including Pharmaceutical Products and Business Development Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for patient treatment and adverse event reporting
Services for partnerships and investor engagement
Unlock access to complete
Funding Insights of Assertio
- Total Funding Total Funding
- Total Rounds 5
- Last Round Debt – Conventional — $575.0M
-
First Round
First Round
(24 Feb 1998)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Debt – Conventional - Assertio | Valuation |
investors |
|
| Sep, 2014 | Amount | Post-IPO - Assertio | Valuation |
investors |
|
| Jun, 2008 | Amount | Debt – Conventional - Assertio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Assertio
Assertio has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Finance, HBM Healthcare Investments and Biovail. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
Lumira Ventures is engaged in life sciences venture capital investment.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Assertio
Assertio has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include OTREXUP and Spectrum Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Methotrexate injections are offered via the official Otrexup website.
|
2012 | ||||
|
Small molecule therapeutics for oncology and hematology are developed.
|
1987 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Assertio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Assertio Comparisons
Competitors of Assertio
Assertio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flexion Therapeutics, Cara Therapeutics, Eliem Therapeutics, Ethypharm and Zogenix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for pain relief and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| domain | founded_year | HQ Location |
Pain treatment products are developed through reformulation technologies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Assertio
Frequently Asked Questions about Assertio
When was Assertio founded?
Assertio was founded in 1995 and raised its 1st funding round 3 years after it was founded.
Where is Assertio located?
Assertio is headquartered in Lake Forest, United States. It is registered at Lake Forest, California, United States.
How many employees does Assertio have?
As of Dec 31, 2024, the latest employee count at Assertio is 58.
What is the annual revenue of Assertio?
Annual revenue of Assertio is $124.96M as on Dec 31, 2024.
What does Assertio do?
Developer of drugs to treat pain and other neurological diseases. It offers Nucynta ER indicated for the management of pain associated with diabetic peripheral neuropathy (DPN), Gralise for the management of postherpetic neuralgia (PHN), Cambia for acute treatment of migraine attacks, Lazanda for the management of breakthrough pain in cancer patients; and Zipsor, liquid filled capsules for relief of mild to moderate acute pain. Its pipeline developing drugs include cebranopadol, analgesic for the treatment of moderate to severe chronic nociceptive and neuropathic pain.
Who are the top competitors of Assertio?
Assertio's top competitors include Flexion Therapeutics, Cara Therapeutics and Trevena.
What products or services does Assertio offer?
Assertio offers Pharmaceutical Products and Business Development Services.
Is Assertio publicly traded?
Yes, Assertio is publicly traded on NASDAQ under the ticker symbol ASRT.
How many acquisitions has Assertio made?
Assertio has made 2 acquisitions, including OTREXUP, and Spectrum Pharmaceuticals.
Who are Assertio's investors?
Assertio has 11 investors. Key investors include Oxford Finance, HBM Healthcare Investments, Biovail, Deerfield, and GE Healthcare Equipment Finance.
What is Assertio's ticker symbol?
The ticker symbol of Assertio is ASRT on NASDAQ.